August 28, 2016 4:59 AM ET


Company Overview of Nurel Therapeutics, Inc.

Company Overview

Nurel Therapeutics, Inc., a biotechnology company, develops products to treat and manage pain and peripheral nerve damage. Its gene-based therapeutic product, NPE1, delivers enkephalin directly to the peripheral nerve cells and reduces pain in animal models. The company’s drug delivery technology is a gene-based therapy that selectively targets neurons for the treatment of chronic pain due to diabetes, spinal cord injuries, and cancer. Nurel was founded in 2003 and is based in Pittsburgh, Pennsylvania. As of December 16, 2005, Nurel Therapeutics, Inc. is a subsidiary of Mertiva AB (publ).

100 Technology Drive

Suite 400

Pittsburgh, PA 15219

United States

Founded in 2003





Key Executives for Nurel Therapeutics, Inc.

Co-founder, President and Director
Co-founder and Chairman of Scientific Advisory Board
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Nurel Therapeutics, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at